Glucocorticoid-induced osteoporosis is the leading cause of secondary osteoporosis, with rapid bone loss occurring shortly after starting treatment.
The use of oral glucocorticoids significantly increases the risk of spine and hip fractures, with even low doses contributing to this risk.
Preventive measures, including calcium and vitamin D supplementation and antiresorptive agents, can help mitigate bone loss, but many patients do not receive appropriate advice or treatment for this condition.